89377MAB5
Transmedics Group, Inc.
Could not find a ticker for this position, may be a filing error
A medical technology company that makes the Organ Care System, a portable device that keeps donor hearts, lungs, and livers warm, beating, and functioning outside the body during transport—a shift from the old method of packing organs on ice. Founded in 1998 by cardiac surgeon Dr. Waleed Hassanein, the company's name blends "transplant" and "medics." Its machines let transplant teams assess and preserve organs in a near-living state while they travel to recipients.
CONVERTIBLEUnderlying: TMDXCUSIP: 89377MAB5HealthcareUS1 derivative reporter
1.5% convertible senior notes due June 1, 2028
No tracked superinvestor held this security as stock in this period — only the derivative positions below reference it.
Derivative Reporters
Investor
Kind
13F reported value
Quantity
Change
